Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ciliatech Raises €3.5M in Series A Funding
Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, […]
Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat" Autoimmune Diseases
Biotechnology company Maxion Therapeutics has announced it has been awarded a prestigious GBP £2 million […]
Oxford Biotech Secures £13.2m to Develop World’s First Treatment for Rare, Incurable and Deadly Disease
SynaptixBio, whose aim is to develop a treatment for the rare genetic central nervous system […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies
VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck […]
Consumer Longevity Company Tally Health™ Announces $10M Seed Round Led by Forerunner Ventures with Celebrity Participation
Tally Health, a revolutionary consumer biotechnology company created to change the way we age, announces […]
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
Canaan today announced $850 million in new capital to continue the firm’s 35-year history of […]
Felix Raises $18M CDN to Scale On-Demand Treatment for Everyday Health
Felix, Canada’s leading provider of on-demand treatment for everyday health, announces it has completed its […]
Cystic Fibrosis Foundation Commits Up to $15.5M in Additional Funding for Potential Enzyme Therapy
The Cystic Fibrosis Foundation recently agreed to provide up to $15.5 million to Anagram Therapeutics […]
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
Vivani Medical, an emerging biopharmaceutical company that develops miniaturized, subdermal implants has announced that the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more